Search Orphan Drug Designations and Approvals
-
Generic Name: | sarizotan |
---|---|
Date Designated: | 07/07/2015 |
Orphan Designation: | Treatment of Rett syndrome. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Newron Pharmaceuticals US, Inc. 89 Headquarter Plaza North Suite 1438 Morristown, New Jersey 07960 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-